How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/vitamin-e-400-unt.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Vitamin E 400 UNT — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vitamin E 400 UNT (Vitamin E 400 UNT) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Vitamin/Antioxidant. Area: Nutritional supplementation; Cardiovascular; Antioxidant therapy.

marketed Vitamin/Antioxidant Nutritional supplementation; Cardiovascular; Antioxidant therapy Small molecule Live · refreshed every 30 min

Target snapshot

Vitamin E 400 UNT (Vitamin E 400 UNT) — American British Cowdray Medical Center. Vitamin E acts as a fat-soluble antioxidant that neutralizes free radicals and protects cell membranes from oxidative damage.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Vitamin E 400 UNT TARGET	Vitamin E 400 UNT	American British Cowdray Medical Center	marketed	Vitamin/Antioxidant
High dose vitamin C	High dose vitamin C	Seoul National University Hospital	marketed	Vitamin/Antioxidant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Vitamin/Antioxidant class)

American British Cowdray Medical Center · 1 drug in this class
Seoul National University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vitamin E 400 UNT — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-e-400-unt. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing